NO20015308L - En farmasoytisk formulering som inneholder en inhibitor av karboksypeptidase U og A trombininhibitor - Google Patents

En farmasoytisk formulering som inneholder en inhibitor av karboksypeptidase U og A trombininhibitor

Info

Publication number
NO20015308L
NO20015308L NO20015308A NO20015308A NO20015308L NO 20015308 L NO20015308 L NO 20015308L NO 20015308 A NO20015308 A NO 20015308A NO 20015308 A NO20015308 A NO 20015308A NO 20015308 L NO20015308 L NO 20015308L
Authority
NO
Norway
Prior art keywords
inhibitor
carboxypeptidase
pharmaceutical formulation
formulation containing
thrombin
Prior art date
Application number
NO20015308A
Other languages
English (en)
Norwegian (no)
Other versions
NO20015308D0 (no
Inventor
Magnus Polla
Tommy Abrahamsson
Viveca Nerme
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE9901572A external-priority patent/SE9901572D0/xx
Priority claimed from SE9901573A external-priority patent/SE9901573D0/xx
Priority claimed from SE9902902A external-priority patent/SE9902902D0/xx
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of NO20015308D0 publication Critical patent/NO20015308D0/no
Publication of NO20015308L publication Critical patent/NO20015308L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/57—Protease inhibitors from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO20015308A 1999-05-03 2001-10-30 En farmasoytisk formulering som inneholder en inhibitor av karboksypeptidase U og A trombininhibitor NO20015308L (no)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
SE9901572A SE9901572D0 (sv) 1999-05-03 1999-05-03 New compounds
SE9901573A SE9901573D0 (sv) 1999-05-03 1999-05-03 New compounds
SE9902902A SE9902902D0 (sv) 1999-08-13 1999-08-13 New formulation
PCT/SE2000/000847 WO2000066152A1 (fr) 1999-05-03 2000-05-03 Formulation pharmaceutique contenant un inhibiteur de la carboxypeptidase u et un inhibitor de thrombine

Publications (2)

Publication Number Publication Date
NO20015308D0 NO20015308D0 (no) 2001-10-30
NO20015308L true NO20015308L (no) 2001-12-03

Family

ID=27355973

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20015308A NO20015308L (no) 1999-05-03 2001-10-30 En farmasoytisk formulering som inneholder en inhibitor av karboksypeptidase U og A trombininhibitor

Country Status (26)

Country Link
US (1) US6974800B1 (fr)
EP (1) EP1181048B1 (fr)
JP (1) JP2002543148A (fr)
KR (1) KR100725206B1 (fr)
CN (1) CN100518820C (fr)
AR (1) AR023819A1 (fr)
AT (1) ATE447964T1 (fr)
AU (1) AU763772B2 (fr)
BR (1) BR0010255A (fr)
CA (1) CA2371217A1 (fr)
CZ (1) CZ20013932A3 (fr)
DE (1) DE60043297D1 (fr)
EE (1) EE200100578A (fr)
ES (1) ES2335383T3 (fr)
HK (1) HK1042442B (fr)
HU (1) HUP0201615A3 (fr)
IL (1) IL145951A0 (fr)
IS (1) IS6140A (fr)
MX (1) MXPA01011044A (fr)
MY (1) MY126962A (fr)
NO (1) NO20015308L (fr)
NZ (1) NZ515063A (fr)
SK (1) SK15652001A3 (fr)
TR (1) TR200103151T2 (fr)
TW (1) TWI232106B (fr)
WO (1) WO2000066152A1 (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9901572D0 (sv) * 1999-05-03 1999-05-03 Astra Ab New compounds
EP1152004B1 (fr) 1999-09-14 2003-05-07 Meiji Seika Kaisha Ltd. Derivés d'acides phosphoniques presentant une activité inhibitrice de carboxypeptidase B
SE0001803D0 (sv) 2000-05-16 2000-05-16 Astrazeneca Ab New compounds i
SE0103272D0 (sv) 2001-09-28 2001-09-28 Astrazeneca Ab Chemical compounds
US6713496B2 (en) 2002-01-22 2004-03-30 Pfizer Inc 3-(imidazolyl)-2-alkoxypropanoic acids
BR0307033A (pt) 2002-01-22 2004-12-07 Pfizer ácidos 3-(imidazolil)-2-aminopropanóicos para o uso como inibidores tafi-a para o tratamento de doenças trombóticas
IL163935A0 (en) 2002-03-21 2005-12-18 Schering Ag Plasma carboxypeptidase b inhibitors
US8088728B2 (en) * 2005-06-24 2012-01-03 Drugrecure Aps Airway administration of tissue factor pathway inhibitor in inflammatory conditions affecting the respiratory tract
RU2015156612A (ru) 2013-06-10 2017-07-17 Санофи Макроциклические производные мочевины в качестве ингибиторов tafia, их получение и их применение в качестве фармацевтических средств
EP3569617A1 (fr) * 2018-05-18 2019-11-20 Trion Research GmbH Préparation pharmaceutique pour utilisation dans le traitement chez des patients atteints du virus epstein-barr avec maladies associées au phénomène de réactivation

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3091569A (en) 1960-08-26 1963-05-28 Mead Johnson & Co Mucolytic-nu-acylated sulfhydryl compositions and process for treating animal mucus
FR1393338A (fr) 1964-01-08 1965-03-26 Rech S Pharma Et Scient Nouveau dérivé de la cystéine et sa préparation
US3766206A (en) 1971-11-03 1973-10-16 Pfizer 18beta-glycyrrheting acid amides useful as antiulcer agents
FR2266502A1 (en) 1974-04-08 1975-10-31 Synpharm Sa N-(2-thenoyl)-cysteine and esters - with mucolytic activity, prepd. from cysteine (esters) and thenoyl chloride
US4113715A (en) 1977-01-17 1978-09-12 E. R. Squibb & Sons, Inc. Amino acid derivatives
US4177277A (en) 1977-01-17 1979-12-04 E. R. Squibb & Sons, Inc. Method for alleviating hypertension
JPS545949A (en) 1977-06-16 1979-01-17 Hisamitsu Pharmaceut Co Inc Novel cyclohexanecarboxylic acid and its derivatives
FR2430945A2 (fr) 1978-07-12 1980-02-08 Chauvin Blache Lab Nouveaux derives de la cysteine, leur procede de fabrication et leur application en therapeutique
US4708965A (en) 1985-09-16 1987-11-24 Morgan Lee R Method of treating herpes virus infections with N,N'-diacetylcystine and derivatives
DE3838467C2 (de) 1988-11-12 1998-12-10 Agfa Gevaert Ag Fotografisches Aufzeichnungsmaterial
US5206161A (en) * 1991-02-01 1993-04-27 Genentech, Inc. Human plasma carboxypeptidase B
IT1249650B (it) 1991-05-29 1995-03-09 Poli Ind Chimica Spa N-(5-tioxo-l-prolil)-l-cisteina e suoi derivati, loro preparazione ed impiego terapeutico
SE9103612D0 (sv) * 1991-12-04 1991-12-04 Astra Ab New peptide derivatives
SE9301916D0 (sv) * 1993-06-03 1993-06-03 Ab Astra New peptides derivatives
SE9404196D0 (sv) 1994-12-02 1994-12-02 Astra Ab New antithrombotic formulation
KR0173034B1 (ko) 1995-04-28 1999-03-30 성재갑 선택적 트롬빈 억제제
GB9525620D0 (en) * 1995-12-15 1996-02-14 Glaxo Group Ltd Chemical compounds
US5859271A (en) * 1996-04-15 1999-01-12 Virginia Commonwealth University Cytoprotective compounds
US6126939A (en) * 1996-09-03 2000-10-03 Yeda Research And Development Co. Ltd. Anti-inflammatory dipeptide and pharmaceutical composition thereof
US5993815A (en) * 1996-11-08 1999-11-30 University Of Vermont Methods and compositions for inhibiting the activation of thrombin-activatable fibrinolysis inhibitor (TAFI)
AU6959898A (en) * 1997-04-11 1998-11-11 David J. Grainger Compounds and therapies for the prevention of vascular and non-vascular pathol ogies

Also Published As

Publication number Publication date
SK15652001A3 (sk) 2002-07-02
AU763772B2 (en) 2003-07-31
JP2002543148A (ja) 2002-12-17
IS6140A (is) 2001-11-01
EP1181048A1 (fr) 2002-02-27
BR0010255A (pt) 2002-02-13
HK1042442B (zh) 2010-04-09
HUP0201615A3 (en) 2006-07-28
IL145951A0 (en) 2002-07-25
AU4447200A (en) 2000-11-17
DE60043297D1 (de) 2009-12-24
WO2000066152A1 (fr) 2000-11-09
KR20020003386A (ko) 2002-01-12
MY126962A (en) 2006-11-30
EP1181048B1 (fr) 2009-11-11
CN100518820C (zh) 2009-07-29
ES2335383T3 (es) 2010-03-26
HK1042442A1 (en) 2002-08-16
KR100725206B1 (ko) 2007-06-07
AR023819A1 (es) 2002-09-04
TR200103151T2 (tr) 2002-04-22
CZ20013932A3 (cs) 2002-04-17
EE200100578A (et) 2003-02-17
HUP0201615A2 (en) 2002-09-28
MXPA01011044A (es) 2002-06-04
PL356119A1 (en) 2004-06-14
TWI232106B (en) 2005-05-11
NZ515063A (en) 2003-08-29
CN1350463A (zh) 2002-05-22
NO20015308D0 (no) 2001-10-30
CA2371217A1 (fr) 2000-11-02
US6974800B1 (en) 2005-12-13
ATE447964T1 (de) 2009-11-15

Similar Documents

Publication Publication Date Title
ID27394A (id) Kombinasi farmasi yang mengandung inhibitor cox-2 dan inhibitor inos
PT1105123E (pt) Composicoes farmaceuticas contendo inibidores da lipase e quitosano
NO20021401D0 (no) Konazolinforbindelser og farmasöytiske preparater inneholdende slike forbindelser
PT1306082E (pt) Inaladores de dose calibrada pressurizada e formulacoes farmaceuticas de aerossol
DK1036062T3 (da) Hydroxamsyrederivater som matrix metalloprotease (MMP) inhibitorer
HUP0105077A3 (en) Serine protease inhibitors and pharmaceutical compositions containing them
ATE293970T1 (de) Lipasehemmer enthaltende pharmazeutische zusammensetzungen
IL128914A (en) Heteroaryl succinamide metalloproteinase inhibitors and pharmaceutical compositions containing them
NO982809D0 (no) Prolegemidler av tombin-inhibitorer
NO974069L (no) Orale farmasöytiske doseringsformer omfattende en protonpumpeinhibitor og et NSAID
IL209444A0 (en) O-desmethyl-venlafaxine succinate salts and pharmaceutical compositions containing them
NO20014895L (no) Farmasöytisk formulering innbefattende et bisfosfonat og et additivmiddel som gir foröket adsorpsjon av bisfosfonatet
NO20001914D0 (no) <alfa>-Aryl-N-alkylnitroner og farmasøytiske blandinger som inneholder slike
IL128664A (en) Heterocyclic metalloprotease inhibitors and pharmaceutical compositions comprising them
NO20011950L (no) Farmasöytiske blandinger som inneholder poly(ADP-ribose) glukohydrolaseinhibitorer og fremgangsmåter for anvendelse avsamme
AU7294098A (en) Metalloproteinase inhibitors, pharmaceutical compositions containing them and their pharmaceutical uses
HUP0400328A3 (en) Metalloproteinase inhibitor azoles and pharmaceutical compositions containing them
NO20015107D0 (no) En farmasöytisk formulering som innbefatter en trombininhibitor med lav molekylvekt og dens prodrug
NO20015308L (no) En farmasoytisk formulering som inneholder en inhibitor av karboksypeptidase U og A trombininhibitor
HUP0100082A3 (en) Thrombin inhibitor, peptide derivatives, pharmaceutical compositions comprising thereof and their use
NO306114B1 (no) Substituerte 4-fenyltiazolderivater og farmasöytiske blandinger som inneholder dem
EE200200032A (et) Interleukiin-18 inhibiitorite kasutamine metastaaside pärssimiseks sobivate ravimite valmistamiseksning selliseid inhibiitoreid sisaldav farmatseutiline kompositsioon
NO20013816D0 (no) Benzamidderivater og legemidler som inneholder disse
NO20024354D0 (no) N-deacetyltiocolchicin-derivater og farmasöytiske sammensetninger inneholdende dem
EE200300161A (et) Triasooliderivaadid ja neid sisaldavad farmatseutilised kompositsioonid

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application